Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Russians Mourn Iconic Rheumatologist

Paul H. Caldron, DO, and Igor Tartakovsky, MD  |  May 16, 2011

Valentina A. Nasonova, MD, was Renaissance figure in Russian rheumatology

Congress Spending More Time at Home: Good News for Advocates

Staff  |  May 16, 2011

Members of Congress will spend more time in their respective districts this year. This is great news for both experienced and new advocates, because members of Congress are often more accessible when they are home. If you are apprehensive about meeting with your members of Congress in Washington, D.C., these district work periods provide the perfect opportunity to begin building a valuable relationship with your legislators. Here are a few ways for you to reach out to your legislators while they are at home.

RA Treatment May Be Beneficial Even After Patients Meet Remission Criteria

Staff  |  May 16, 2011

An analysis of wrist MRIs from participants in the Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) clinical trial indicates that patients continue to show joint inflammation even after two years of early aggressive therapy.

New Research Shows Chondroitin Sulphate Reduces Cartilage Volume Loss, Bone Marrow Lesions

Sue Pondrom  |  May 13, 2011

However, conflicting data and small study size make it difficult to draw firm conclusions

Lupus Patients Have More Lethal Form of Kidney Disease

Sue Pondrom  |  April 13, 2011

SLE patients with ESRD at increased risk of death

Public-Private Partnership Takes ACTION Against Pain

Kevin Stevens  |  April 13, 2011

New initiative seeks to improve clinical trials, develop novel analgesics

Are We There Yet?

David Borenstein, MD  |  April 13, 2011

Advancing rheumatology through public relations

Trillions of SNPs Versus a Glass of Grappa

David S. Pisetsky, MD  |  April 13, 2011

Will personalized medicine make us healthier or just contribute to information overload?

Treat Rheumatoid Arthritis to Target

Elana J. Bernstein, MD; Allan Gibofsky, MD, JD  |  April 13, 2011

The time has come for goal-directed management of RA

Promoting Arthritis Research to Congress and Others

Staff  |  April 13, 2011

The ACR works to promote clinical and basic research in arthritis and musculoskeletal disease through a variety of channels, including advocacy, working directly with the National Institutes of Health (NIH), and through the work of the ACR Research and Education Foundation.

  • « Previous Page
  • 1
  • …
  • 270
  • 271
  • 272
  • 273
  • 274
  • …
  • 309
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences